ArticleInvestigational new drugs2021

Phase I clinical trial of temozolomide and methoxyamine (TRC-102), an inhibitor of base excision repair, in patients with advanced solid tumors.

Jennifer R Eads et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.